Parkland Policy and Preventive Ethics (EM2412A)
This course is a 7-part, on-demand series developed by Parkland Health and provides a foundation of recent policy updates to ensure the audience has the legal context in which to undertake the ethical analysis of complex health care decisions. Legal representatives and leaders in clinical ethics at Parkland have collaborated with colleagues in the Learning and Development department to develop this educational content.
Method of Participation
This continuing medical education enduring material is in a video format.
To receive AMA PRA Category 1 Credit(s)™ you should:
- View the video in this enduring material.
- Complete the posttest.
- Complete and submit the CME evaluation form.
Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.
If you have questions about the participation process, please e-mail the UT Southwestern Medical Center, CEOffice@utsouthwestern.edu or phone 214-648-2166.
Target Audience
The content will be designed to capture the audience’s attention of key updates and complex ethical cases and is appropriate for all active Parkland medical staff members of Parkland Health.
Learning Objectives
Module #1: Foundation: Informed Consent Policy Updates
- Identify the importance of decision-making capacity assessment when obtaining patient consent
- Recognize the legal hierarchy of priority for surrogate decision-making on behalf of the incapacitated patient
- Discuss the difference in implied consent in emergent procedures and two-physician authorization in non-emergent procedures for unrepresented individuals
- Describe the role of interdisciplinary team members to protect the patient’s rights to appropriate informed consent processes
Module #2: Ethics: Authorization, Consent and Vulnerable Individuals
- Identify how to extend the right to self-determination to the authority granted by the law to individuals to represent the incapacitated patient’s interests
- Define beneficence and non-maleficence in the authorization of proceeding with a procedure for the incapacitated patient in the absence of their ability to provide consent for themselves
- Adopt a common language to focus on the authority granted by law to be a legally-authorized representative (LAR) or legally-authorized surrogate decision-maker (LASDM) on behalf of the incapacitated patient
Module #3 Foundation: Texas Advance Directive Act Updates
- Discuss the history of the Texas Advance Directive Act
- Identify the substantive changes to the Texas Advance Directive Act in HB 3162
- Discuss strategies for applying these changes to practice in order to protect the rights of the patient or surrogate decision-maker
- Recognize opportunities to involve Ethics and Legal colleagues early in treatment disputes.
Module #4: Disability Ethics
- Identify the authority provided to the ethics committee in dispute resolution for life-sustaining treatment as outlined in the Texas Advance Directive Act
- Define disability as utilized in the Texas Advance Directive Act
- Recognize biased language and ableist bias
- Identify and discuss ways to improve the quality and equity of care provided to individuals with disabilities
Module #5: Foundation: Incapacity Holds
- Identify the similarities of the laws providing various emergency detention procedures
- Discuss the limitations of the laws providing various emergency detention procedures
- Identify barriers people with mental health illness face in accessing health care
Module #6: Medical Incapacity and the Vulnerable
- Discuss the limits of emergency detention laws for mental illness
- Discuss ethical concerns underlying the limitations of detention for those with medical incapacity
- Summarize and discuss the medical incapacity holds that exist in other states or institutions
Module 7: Safe and Effective Pain Management – Education on Prescribing Opioids
- Recognize criteria for assessment of a patient’s pain
- Compare pharmacologic and non-pharmacologic interventions for pain management
- Recognize symptoms of patients at risk for respiratory depression and define appropriate use of IV and intranasal naloxone
- Identify the Medications for Opioid Use Disorder (MOUD)
- Define opioid stewardship, CDC guidelines, and requirements by the Texas Medical Board (TMB)
Brad Nitschke, J.D.
Jennifer Wimberly, MD, HCE-C
Carol Chamberlain, PharmD, MA
Danielle Hernandez, MSW, LCSW
Enas Kandil, MD, Msc
Subhasri Kannan, M.D Internal Medicine
Jessica Rong, MSN, RN, CCRN
Carol Chamberlain, PharmD, MA
Danielle Hernandez, MSW, LCSW
Enas Kandil, MD, Msc
Subhasri Kannan, M.D Internal Medicine
Abby Lau, MD
Lauryn Minter, Ph.D.
Carl Mirus IV, MD
Brad Nitschke, J.D.
Catherine Quintana, BSN, RNC-OB, CPLC, RTSCBC
Jessica Rong, MSN, RN, CCRN
John Sadler, Professor of Psychiatry & Foster Professor of Ethics
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas Southwestern Medical Center and Parkland Health and Hospital System. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
This activity is approved for AMA Category 1 Credit(s)TM.
Price
REGISTRATION
To register:
- Select the link embedded in the session title for the session you wish to enroll.
- Once in the activity, select the "Register" tab or the "Take course" button to proceed to the activity.
Required Hardware/software
Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.